Laboratoire d'Hématologie, Center Hospitalier Universitaire (CHU) Bicêtre, Assistance publique - Hôpitaux de Paris (AP-HP), Le Kremlin-Bicêtre.
Université Paris Sud Paris Saclay, Faculté de Pharmacie, Chatenay Malabry.
Haematologica. 2019 Aug;104(8):1554-1564. doi: 10.3324/haematol.2018.205328. Epub 2019 Jan 17.
We describe the clinical, hematologic and genetic characteristics of a retrospective series of 126 subjects from 64 families with hereditary xerocytosis. Twelve patients from six families carried a mutation, five had the recurrent p.Arg352His mutation and one had a new deletion at the exon 7-intron 7 junction. Forty-nine families carried a mutation, which was a known recurrent mutation in only one-third of the cases and private sequence variation in others; 12 new probably pathogenic missense mutations were identified. The two dominant features leading to diagnosis were hemolysis that persisted after splenectomy and hyperferritinemia, with an inconstant correlation with liver iron content assessed by magnetic resonance imaging. -hereditary xerocytosis was characterized by compensated hemolysis in most cases, perinatal edema of heterogeneous severity in more than 20% of families and a major risk of post-splenectomy thrombotic events, including a high frequency of portal thrombosis. In -related disease, the main symptoms were more severe anemia, hemolysis and iron overload, with no clear sign of red cell dehydration; therefore, this disorder would be better described as a 'Gardos channelopathy'. These data on the largest series to date indicate that -hereditary xerocytosis and Gardos channelopathy are not the same disease although they share hemolysis, a high rate of iron overload and inefficient splenectomy. They demonstrate the high variability in clinical expression as well as genetic bases of -hereditary xerocytosis. These results will help to improve the diagnosis of hereditary xerocytosis and to provide recommendations on the clinical management in terms of splenectomy, iron overload and pregnancy follow-up.
我们描述了遗传性血红细胞增多症的 64 个家系 126 例回顾性系列患者的临床、血液学和遗传学特征。6 个家系的 12 例患者携带 突变,5 例患者具有反复出现的 p.Arg352His 突变,1 例患者在第 7 外显子-第 7 内含子交界处发生新的缺失。49 个家系携带 突变,该突变仅在三分之一的病例中是已知的复发性突变,而在其他病例中则是个体序列变异;发现了 12 种新的可能致病性错义突变。导致诊断的两个主要特征是脾切除后持续存在的溶血和高血铁蛋白血症,且与通过磁共振成像评估的肝脏铁含量之间存在不定的相关性。遗传性血红细胞增多症的特征是大多数情况下代偿性溶血,超过 20%的家系存在围产期不同程度的水肿,且脾切除后发生血栓事件的风险较大,包括门静脉血栓形成的高频率。在 -相关疾病中,主要症状是更严重的贫血、溶血和铁过载,没有明显的红细胞脱水迹象;因此,这种疾病最好被描述为“Gardos 通道病”。这些迄今为止最大系列的研究数据表明,遗传性血红细胞增多症和 Gardos 通道病虽然都具有溶血、高铁过载和脾切除无效,但它们并不是同一种疾病。它们表明遗传性血红细胞增多症的临床表现和遗传基础存在高度变异性。这些结果将有助于改善遗传性血红细胞增多症的诊断,并为脾切除、铁过载和妊娠随访的临床管理提供建议。